000 01472 a2200397 4500
005 20250516073702.0
264 0 _c20120709
008 201207s 0 0 eng d
022 _a1460-2091
024 7 _a10.1093/jac/dkr572
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNatto, Manal J
245 0 0 _aValidation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cApr 2012
300 _a933-43 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntiprotozoal Agents
_xpharmacology
650 0 4 _aFemale
650 0 4 _aFluorescence
650 0 4 _aHigh-Throughput Screening Assays
_xmethods
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOxazines
_xmetabolism
650 0 4 _aParasitic Sensitivity Tests
_xmethods
650 0 4 _aPropidium
_xmetabolism
650 0 4 _aStaining and Labeling
_xmethods
650 0 4 _aTrichomonas vaginalis
_xdrug effects
650 0 4 _aXanthenes
_xmetabolism
700 1 _aSavioli, Francesca
700 1 _aQuashie, Neils B
700 1 _aDardonville, Christophe
700 1 _aRodenko, Boris
700 1 _ade Koning, Harry P
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 67
_gno. 4
_gp. 933-43
856 4 0 _uhttps://doi.org/10.1093/jac/dkr572
_zAvailable from publisher's website
999 _c21474175
_d21474175